UNSPSC 51372040: Nalbuphine hydrochloride

This classification denotes an opioid receptor agonist and opioid with the molecular formula C21H27NO4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZU4275277R, chemically known as 17-(cyclobutylmethyl)-4,5alpha-epoxymorphinan-3,6alpha,14-triol hydrochloride but more generally known as nalbuphine hydrochloride, which bears US NIH Compound Identifier 5360733. European Medicines Agency schedules Nalbuphine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14626MIG.

UNSPSC 51372040 Nalbuphine hydrochloride is a Commodity code addressing pharmaceutical procurement by state and local health agencies. The recent activity under this code shows state and local governments purchasing opioid-antagonist medications and related harm-reduction systems to support community health and substance-abuse response programs, though the single sourced opportunity concerns naloxone and drug deactivation systems rather than nalbuphine specifically—suggesting either a coding mismatch in the procurement record or a broader purchasing pattern under this pharmaceutical family. Issuing bodies have included county health departments and community health authorities pursuing competitive bidding processes to meet recurring annual demand for these critical public-health supplies.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The bid deadline was July 26, 2023, at 2:00 pm, with responses submitted electronically through the county's e-Procurement Portal. The contract carried a two-year initial term with a one-year renewal option, fixed-fee pricing, drug-free workplace and E-Verify compliance requirements, and potential FEMA funding with attendant federal environmental and audit obligations. This represents the primary recent activity visible under the code; broader geographic spread and issuing-body concentration cannot be characterized from a single opportunity record.